Exorbitant costs of gene therapy raise payment concerns for patients and government

Exorbitant costs of gene therapy raise payment concerns for patients and government

[Editor's note: Executives from several companies developing gene therapies gathered for a panel discussion at the recent Forbes Healthcare Summit, ...

Craig Venter’s goal is to sequence 100 million genomes

[Craig] Venter’s goal is to sequence at least one million genomes, something that seems likely to take the better part of ...